




HIV-Integrase-Inhibitors-Modulators-MCE.docx 免費(fèi)下載
版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
1、 HYPERLINK https:/www.MedChemE/Targets/HIV Integrase.html HIV HYPERLINK https:/www.MedChemE/Targets/HIV Integrase.html HYPERLINK https:/www.MedChemE/Targets/HIV Integrase.html IntegraseHIV integrase is one of the three key enzymes of the pol gene of HIV. HIV integrase catalyzes the insertion into th
2、e genome of theinfected human cell of viral DNA produced by the retrotranscription process. This unique step in the virus life cycle provides avariety of points for intervention and hence is an attractive target for the development of new therapeutics for the treatment ofAIDS. HIV integrase includes
3、 HIV-1 and HIV-2 integrases.HIV-1 integrase is a 32-kDa enzyme that carries out DNA integration in a two-step reaction. In the first step, called 3 processing,two nucleotides are removed from each 3 end of the viral DNA made by reverse transcription. In the next step, called DNA strandtransfer, a pa
4、ir of transesterification reactions integrates the ends of the viral DNA into the host genome. Integrase is comprised ofthree structurally and functionally distinct domains, and all three domains are required for each step of the integration reaction.www.MedChemE 1 HYPERLINK https:/www.MedChemE/Targ
5、ets/HIV Integrase.html HIV HYPERLINK https:/www.MedChemE/Targets/HIV Integrase.html HYPERLINK https:/www.MedChemE/Targets/HIV Integrase.html Integrase HYPERLINK https:/www.MedChemE/Targets/HIV Integrase.html HYPERLINK https:/www.MedChemE/Targets/HIV Integrase.html Inhibitors HYPERLINK https:/www.Med
6、ChemE/s-bi-1001.html (S)-BI-1001 HYPERLINK https:/www.MedChemE/s-bi-1001.html HYPERLINK https:/www.MedChemE/_plusmn_-BI-D.html ()-BI-DCat. No.: HY-12210 Cat. No.: HY-18601(S)-BI-1001 (Compound 11) is an activeS-enantiomer of BI-1001. (S)-BI-1001 exhibitsantiviral potency against HIV-1 integrase with
7、 anIC50 of 28 nM, an EC50 of 450 nM and a Kd of4.7 M.()-BI-D is a potent ALLINI(An allosteric INinhibitor) that binds integrase at the LEDGF/p75binding site.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98.02%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10
8、 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/BI-224436.html BI HYPERLINK https:/www.MedChemE/BI-224436.html HYPERLINK https:/www.MedChemE/BI-224436.html 224436Cat. No.: HY-18595 HYPERLINK https:/www.MedChemE/Bictegravir.html Bictegravir(GS-9883) Cat. No.: HY-17605BI 224436 is a novel HIV-1 nonca
9、talytic siteintegrase inhibitor with EC values of less50than 15 nM against different HIV-1 laboratorystrains.Bictegravir (GS-9883) is a potent inhibitor ofHIV-1 integrase with an IC of 7.5 nM.50Purity: 99.74%Clinical Data: Phase 1Size: 5 mg, 10 mg, 50 mg, 100 mgPurity: 99.88%Clinical Data: LaunchedS
10、ize: 10 mM 1 mL, 1 mg, 5 mg, 10 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/BMS-707035.html BMS-707035Cat. No.: HY-13269 HYPERLINK https:/www.MedChemE/Cabotegravir.html Cabotegravir(GSK-1265744; S/GSK1265744) Cat. No.: HY-15592BMS-707035 is an HIV-1 integrase (IN) inhibitorwith an IC50 value of
11、15 nM.Cabotegravir is a potent HIV integrase inhibitoras an oral lead-in tablet and long-actinginjectable for the treatment and prevention of HIVinfection. Cabotegravir is an inhibitor of OAT1(IC50 0.81 M) and OAT3 (IC50 0.41 M).Purity: 99.50%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5
12、 mg, 10 mg, 50 mg, 100 mgPurity: 98.04%Clinical Data: LaunchedSize: 10 mM 1 mL, 10 mg, 25 mg, 50 mg HYPERLINK https:/www.MedChemE/cabotegravir-d3.html Cabotegravir-d3 HYPERLINK https:/www.MedChemE/cabotegravir-d3.html HYPERLINK https:/www.MedChemE/cabotegravir-d5.html Cabotegravir-d5(GSK-1265744-d3;
13、 S/GSK1265744-d3) Cat. No.: HY-15592S (GSK-1265744-d5; S/GSK1265744-d5) Cat. No.: HY-15592S1Cabotegravir-d3 (GSK-1265744-d3) is the deuteriumlabeled Cabotegravir. Cabotegravir is a potent HIVintegrase inhibitor as an oral lead-in tablet andlong-acting injectable for the treatment andprevention of HI
14、V infection.Cabotegravir-d5 is deuterium labeled Cabotegravir.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/Dolutegravir.html Dolutegravir HYPERLINK https:/www.MedChemE/Dolutegravir.htm
15、l HYPERLINK https:/www.MedChemE/Dolutegravir-sodium.html Dolutegravir HYPERLINK https:/www.MedChemE/Dolutegravir-sodium.html HYPERLINK https:/www.MedChemE/Dolutegravir-sodium.html sodium(S/GSK1349572) Cat. No.: HY-13238 (S/GSK1349572 sodium) Cat. No.: HY-13238ADolutegravir (S/GSK1349572) is a highly
16、 potent andorally bioavailable HIV integrase strand transferinhibitor with an IC of 2.7 nM for HIV-150integrase-catalyzed strand transfer.Dolutegravir sodium (S/GSK1349572 sodium) is ahighly potent and orally bioavailable HIV integrasestrand transfer inhibitor with an IC of 2.7 nM50for HIV-1 integra
17、se-catalyzed strand transfer.Purity: 99.65%Clinical Data: LaunchedSize: 10 mM 1 mL, 2 mg, 5 mg, 10 mg, 50 mg, 100 mg, 200 mgPurity: 99.88%Clinical Data: LaunchedSize: 10 mM 1 mL, 2 mg, 5 mg, 10 mg, 50 mg, 100 mg2 Tel: 609-228-6898 Fax: 609-228-5909 Email: salesMedChemE HYPERLINK https:/www.MedChemE/
18、dolutegravir-d3.html Dolutegravir-d3(S/GSK1349572-d3) Cat. No.: HY-13238S1 HYPERLINK https:/www.MedChemE/dolutegravir-d5.html Dolutegravir-d5(S/GSK1349572-d5) Cat. No.: HY-13238S2Dolutegravir-d3 (S/GSK1349572-d3) is the deuteriumlabeled Dolutegravir. Dolutegravir (S/GSK1349572)is a highly potent and
19、 orally bioavailable HIVintegrase strand transfer inhibitor with an IC50of 2.7 nM for HIV-1 integrase-catalyzed strandtransfer.Dolutegravir-d5 is deuterium labeled Dolutegravir.Dolutegravir (S/GSK1349572) is a highly potent andorally bioavailable HIV integrase strand transferinhibitor with an IC50 o
20、f 2.7 nM for HIV-1integrase-catalyzed strand transfer.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/dolutegravir-d6-sodium.html Dolutegravir-d6 HYPERLINK https:/www.MedChemE/dolutegravi
21、r-d6-sodium.html HYPERLINK https:/www.MedChemE/dolutegravir-d6-sodium.html sodium(S/GSK1349572-d6 sodium) Cat. No.: HY-13238AS HYPERLINK https:/www.MedChemE/Elvitegravir.html Elvitegravir(GS-9137; JTK-303; D06677) Cat. No.: HY-14740Dolutegravir-d6 sodium (S/GSK1349572-d6 sodium) isthe deuterium labe
22、led Dolutegravir sodium.Elvitegravir (GS-9137; JTK-303; D06677) is an HIVintegrase inhibitor for HIV-1 , HIV-2 andIIIB EHOHIV-2 with of 0.7 nM, 2.8 nM and 1.4 nM,respectively.ROD IC50Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 99.85%Clinical Data: LaunchedSize: 10 mM 1 m
23、L, 10 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/elvitegravir-d8.html Elvitegravir-d8(GS-9137-d8; JTK-303-d8; D06677-d8) Cat. No.: HY-14740S HYPERLINK https:/www.MedChemE/equisetin.html EquisetinCat. No.: HY-N6711Elvitegravir-d8 is deuterium labeled Elvitegravir.Elvitegravir (GS-9137; JTK-303;
24、D06677) is an HIVintegrase inhibitor for HIV-1IIIB, HIV-2EHO andHIV-2ROD with IC50 of 0.7 nM, 2.8 nM and 1.4 nM,respectively.Equisetin is an N-methylserine-derived acyltetramic acid isolated from a terrestrial fungusFusarium equiseti NRRL 5537. Equisetin is atetramate-containing natural product with
25、antibiotic and cytotoxic activity.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98.12%Clinical Data: No Development ReportedSize: 1 mg, 5 mg, 10 mg HYPERLINK https:/www.MedChemE/HIV-1-integrase-inhibitor.html HIV-1 HYPERLINK https:/www.MedChemE/HIV-1-integrase-inhibitor.ht
26、ml HYPERLINK https:/www.MedChemE/HIV-1-integrase-inhibitor.html integrase HYPERLINK https:/www.MedChemE/HIV-1-integrase-inhibitor.html HYPERLINK https:/www.MedChemE/HIV-1-integrase-inhibitor.html inhibitor HYPERLINK https:/www.MedChemE/HIV-1-integrase-inhibitor.html HYPERLINK https:/www.MedChemE/HIV
27、-1_integrase_inhibitor_3.html HIV-1 HYPERLINK https:/www.MedChemE/HIV-1_integrase_inhibitor_3.html HYPERLINK https:/www.MedChemE/HIV-1_integrase_inhibitor_3.html integrase HYPERLINK https:/www.MedChemE/HIV-1_integrase_inhibitor_3.html HYPERLINK https:/www.MedChemE/HIV-1_integrase_inhibitor_3.html in
28、hibitor HYPERLINK https:/www.MedChemE/HIV-1_integrase_inhibitor_3.html HYPERLINK https:/www.MedChemE/HIV-1_integrase_inhibitor_3.html 3Cat. No.: HY-13025 Cat. No.: HY-108817HIV-1 integrase inhibitor is uesful for anti-HIV.HIV-1 integrase inhibitor 3 is a HIV-1 integrasestrand transfer (INST) inhibit
29、or with an IC of502.7 nM.Purity: 96.37%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 10 mg, 50 mg, 100 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/HIV-1_integrase_inhibitor_4.html HIV-1 HYPERLINK https:/www.MedChemE/HIV-1_integrase_inhi
30、bitor_4.html HYPERLINK https:/www.MedChemE/HIV-1_integrase_inhibitor_4.html integrase HYPERLINK https:/www.MedChemE/HIV-1_integrase_inhibitor_4.html HYPERLINK https:/www.MedChemE/HIV-1_integrase_inhibitor_4.html inhibitor HYPERLINK https:/www.MedChemE/HIV-1_integrase_inhibitor_4.html HYPERLINK https
31、:/www.MedChemE/HIV-1_integrase_inhibitor_4.html 4 HYPERLINK https:/www.MedChemE/HIV-1_integrase_inhibitor_4.html HYPERLINK https:/www.MedChemE/hiv-1-integrase-inhibitor-7.html HIV-1 HYPERLINK https:/www.MedChemE/hiv-1-integrase-inhibitor-7.html HYPERLINK https:/www.MedChemE/hiv-1-integrase-inhibitor
32、-7.html integrase HYPERLINK https:/www.MedChemE/hiv-1-integrase-inhibitor-7.html HYPERLINK https:/www.MedChemE/hiv-1-integrase-inhibitor-7.html inhibitor HYPERLINK https:/www.MedChemE/hiv-1-integrase-inhibitor-7.html HYPERLINK https:/www.MedChemE/hiv-1-integrase-inhibitor-7.html 7Cat. No.: HY-108820
33、 Cat. No.: HY-130760HIV-1 integrase inhibitor 4 is a HIV-1 integrasestrand transfer (INST) inhibitor with an IC of503.7 nM.HIV-1 integrase inhibitor 7 is a potent HIV-1integrase inhibitor, with an IC of 33.3 nM.50Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Da
34、ta: No Development ReportedSize: 1 mg, 5 mgwww.MedChemE 3 HYPERLINK https:/www.MedChemE/hiv-1-integrase-inhibitor-8.html HIV-1 HYPERLINK https:/www.MedChemE/hiv-1-integrase-inhibitor-8.html HYPERLINK https:/www.MedChemE/hiv-1-integrase-inhibitor-8.html integrase HYPERLINK https:/www.MedChemE/hiv-1-i
35、ntegrase-inhibitor-8.html HYPERLINK https:/www.MedChemE/hiv-1-integrase-inhibitor-8.html inhibitor HYPERLINK https:/www.MedChemE/hiv-1-integrase-inhibitor-8.html HYPERLINK https:/www.MedChemE/hiv-1-integrase-inhibitor-8.html 8 HYPERLINK https:/www.MedChemE/hiv-1-integrase-inhibitor-8.html HYPERLINK
36、https:/www.MedChemE/integracin-b.html Integracin HYPERLINK https:/www.MedChemE/integracin-b.html HYPERLINK https:/www.MedChemE/integracin-b.html BCat. No.: HY-107485 Cat. No.: HY-N7330HIV-1 integrase inhibitor 8 is a HIV-1 integraseinhibitor, compound 8.Integracin B is a potent dimeric alkyl aromati
37、cinhibitor of HIV-1 integrase discovered from thescreening of fungal extracts using an in vitroassay. Integracin B inhibits both coupled andstrand transfer activity of HIV-1 integrase.Purity: 99.88%Clinical Data: No Development ReportedSize: 50 mg, 100 mgPurity: 98%Clinical Data: No Development Repo
38、rtedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/L-Chicoric-Acid.html L-Chicoric HYPERLINK https:/www.MedChemE/L-Chicoric-Acid.html HYPERLINK https:/www.MedChemE/L-Chicoric-Acid.html Acid(-)-Chicoric acid; trans-Caffeoyltartaric acid) Cat. No.: HY-N0457A HYPERLINK https:/www.MedChemE/lavendustin-b
39、.html Lavendustin HYPERLINK https:/www.MedChemE/lavendustin-b.html HYPERLINK https:/www.MedChemE/lavendustin-b.html BCat. No.: HY-108935L-Chicoric Acid (-)-Chicoric acid) is adicaffeoyltartaric acid and a potent, selectiveand reversible HIV-1 integrase inhibitor with anIC50 of 100 nM. L-Chicoric Aci
40、d inhibits HIV-1replication in tissue culture.Lavendustin B is an inhibitor of HIV-1 integraseinteraction with LEDGF/p75 with an IC of 94.0750M. Lavendustin B is an ATP-competitive GLUT1inhibitor with a K of 15 M. Lavendustin B isialso a weak inhibitor of tyrosine kinases.Purity: 99.98%Clinical Data
41、: No Development ReportedSize: 10 mgPurity: 98.04%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/HIV-1-integrase-inhibitor-2.html LEDGIN6(CX05168; CX04328) Cat. No.: HY-10522 HYPERLINK https:/www.MedChemE/mk-2048.html MK-2048Ca
42、t. No.: HY-13305LEDGIN6 (CX05168) is a quinoline-basedprotein-protein interaction inhibitor ofLEDGF/p75 and HIV integrase.MK-2048 is a potent inhibitor of integrase andINR263K with IC50 of 2.6 nM and 1.5 nM,respectively. IC50 Value: 2.6 nM for HIV IntegraseTarget: HIV Integrase MK-2048 is a secondge
43、neration integrase inhibitor, intended to beused against HIV infection.Purity: 98.80%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 50 mgPurity: 98.0%Clinical Data: Phase 1Size: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/pirmitegravir.html Pirmitegravir HYPERLINK https:/www.MedCh
44、emE/pirmitegravir.html HYPERLINK https:/www.MedChemE/raltegravir.html RaltegravirCat. No.: HY-130000(MK-0518) Cat. No.: HY-10353Pirmitegravir is a potent and first-in-classinhibitor of allosteric integrase (ALLINI) thattargets LEDGF/p75 binding site. Pirmitegravirdisplays picomolar IC in human PBMCs
45、 with a5024,000 therapeutic index against HIV-1.Raltegravir is a potent integrase (IN) inhibitor,used to treat HIV infection.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 99.53%Clinical Data: LaunchedSize: 10 mM 1 mL, 5 mg, 10 mg, 50 mg HYPERLINK https:/www.MedChemE/Ralteg
46、ravir-potassium-salt.html Raltegravir HYPERLINK https:/www.MedChemE/Raltegravir-potassium-salt.html HYPERLINK https:/www.MedChemE/Raltegravir-potassium-salt.html potassium HYPERLINK https:/www.MedChemE/Raltegravir-potassium-salt.html HYPERLINK https:/www.MedChemE/raltegravir-d3-potassium-salt.html Raltegravir-d3 HYPERLINK https:/www.MedChemE/raltegravir-d3-potassium-salt.html HYPERLINK https:/www.MedChemE/raltegravir-d3-potassium-salt.html potassium(MK 0518 potassium) Cat. No.: HY-10353A (M
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 紡織機(jī)械的數(shù)字化技術(shù)發(fā)展趨勢(shì)考核試卷
- 統(tǒng)編版語(yǔ)文六年級(jí)下冊(cè)《語(yǔ)文園地一》精美課件
- 紙張耐高溫性能考核試卷
- 纖維板生產(chǎn)過(guò)程中的質(zhì)量管理與控制考核試卷
- 糧油商品知識(shí)與實(shí)踐考核試卷
- 河南省駐馬店市平輿縣2023-2024學(xué)年七年級(jí)下學(xué)期6月期末考試數(shù)學(xué)試卷(含答案)
- 筆的行業(yè)競(jìng)爭(zhēng)現(xiàn)狀考核試卷
- 合成材料在個(gè)人防護(hù)裝備中的應(yīng)用考核試卷
- 家禽飼養(yǎng)業(yè)產(chǎn)學(xué)研深度融合與成果轉(zhuǎn)化機(jī)制優(yōu)化考核試卷
- 二年級(jí)下冊(cè)成語(yǔ)
- 日光溫室大棚承包合同
- 電子商務(wù)案例分析13例 - 電子商務(wù)案例
- 多發(fā)傷及復(fù)合傷的搶救處理流程
- 2023年鄭州科技學(xué)院?jiǎn)握忻嬖囶}庫(kù)及答案解析
- 《表觀遺傳》教學(xué)設(shè)計(jì)
- 自動(dòng)跟隨智能小車的定位與跟隨系統(tǒng)設(shè)計(jì)
- 急性心力衰竭試題附答案
- 房室結(jié)折返性心動(dòng)過(guò)速
- 光伏工程綠色施工、節(jié)能減排方案
- 歷史學(xué)科中考復(fù)習(xí)方法交流
- GB/T 6284-2006化工產(chǎn)品中水分測(cè)定的通用方法干燥減量法
評(píng)論
0/150
提交評(píng)論